FEMMINELLA, GRAZIA DANIELA
 Distribuzione geografica
Continente #
AS - Asia 3.096
EU - Europa 2.559
NA - Nord America 2.410
SA - Sud America 479
AF - Africa 101
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.659
Nazione #
US - Stati Uniti d'America 2.279
SG - Singapore 1.725
RU - Federazione Russa 1.338
CN - Cina 667
IT - Italia 515
BR - Brasile 387
VN - Vietnam 248
HK - Hong Kong 233
NL - Olanda 147
DE - Germania 140
FI - Finlandia 109
IE - Irlanda 73
CA - Canada 71
IN - India 66
GB - Regno Unito 53
FR - Francia 51
AR - Argentina 44
MX - Messico 42
CI - Costa d'Avorio 40
SE - Svezia 34
KR - Corea 33
BD - Bangladesh 26
ZA - Sudafrica 24
PL - Polonia 21
AT - Austria 18
TR - Turchia 14
IQ - Iraq 13
UA - Ucraina 12
JP - Giappone 11
CO - Colombia 10
ES - Italia 10
PK - Pakistan 9
UZ - Uzbekistan 9
ID - Indonesia 8
SA - Arabia Saudita 8
PE - Perù 7
PY - Paraguay 7
BE - Belgio 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
LT - Lituania 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
NG - Nigeria 5
BO - Bolivia 4
DZ - Algeria 4
EG - Egitto 4
MA - Marocco 4
NZ - Nuova Zelanda 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BY - Bielorussia 3
KE - Kenya 3
RS - Serbia 3
SN - Senegal 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
CR - Costa Rica 2
EU - Europa 2
GH - Ghana 2
HN - Honduras 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
MZ - Mozambico 2
OM - Oman 2
PA - Panama 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
CM - Camerun 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HT - Haiti 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NP - Nepal 1
PH - Filippine 1
Totale 8.653
Città #
Singapore 878
Moscow 304
Ashburn 264
Chandler 252
Hong Kong 233
Beijing 210
Naples 169
Dallas 138
Amsterdam 136
Hefei 127
Ho Chi Minh City 97
Santa Clara 93
San Jose 90
Los Angeles 86
Millbury 78
Napoli 67
Munich 58
Boston 56
Princeton 54
Nanjing 44
Des Moines 42
Hanoi 42
Redondo Beach 36
Ottawa 35
Buffalo 34
São Paulo 33
Turku 33
New York 32
The Dalles 29
Seattle 26
Mexico City 25
Seoul 25
Lawrence 24
Orem 24
Wilmington 23
Montreal 22
Chicago 20
Helsinki 20
Warsaw 20
Frankfurt am Main 19
Milan 19
Shenyang 19
Kochi 18
Nuremberg 16
Rio de Janeiro 15
Stockholm 15
Nanchang 14
Washington 14
Atlanta 13
Brooklyn 13
Da Nang 13
Denver 13
Dong Ket 12
Phoenix 12
Hebei 11
Rome 11
Vienna 11
Changsha 10
Houston 10
Johannesburg 10
Poplar 10
Tianjin 10
Council Bluffs 9
Norwalk 9
Belo Horizonte 8
Biên Hòa 8
Boardman 8
Casavatore 8
Chennai 8
Falkenstein 8
Haiphong 8
Jiaxing 8
Pune 8
Tashkent 8
Antalya 7
Campinas 7
Dhaka 7
Dublin 7
Düsseldorf 7
Brembate di Sopra 6
Curitiba 6
Guangzhou 6
Hải Dương 6
London 6
Manchester 6
Roubaix 6
San Francisco 6
Tokyo 6
Vico Equense 6
Bexley 5
Buenos Aires 5
Carapicuíba 5
Feira de Santana 5
Guarulhos 5
Harbin 5
Lappeenranta 5
Lima 5
Ninh Bình 5
Porto Alegre 5
Sant'Anastasia 5
Totale 4.535
Nome #
Management and treatment of cardiovascular diseases in the elderly 178
Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature 143
β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy? 142
Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure 138
microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases 137
Interleukin-17 (IL-17) triggers systemic inflammation, peripheral vascular dysfunction, and related prothrombotic state in a mouse model of Alzheimer's disease 136
Effects of exercise training on cardiovascular adrenergic system 133
Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure 131
Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure 131
Cardiac sympathetic innervation and mortality risk scores in patients with heart failure 130
Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker? 127
Adrenal adrenoceptors in heart failure 126
Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives 126
Age-related and heart failure-related beta-adrenergic receptor dysfunction: New therapeutic strategies for the treatment of cardiovascular diseases 125
Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure 123
Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study 122
Muscle Ultrasound as Imaging Domain of Frailty 121
Impact of the number of comorbidities on cardiac sympathetic derangement in patients with reduced ejection fraction heart failure 120
Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure. 117
Myocardial β2-adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure 116
Impact of aging on cardiac sympathetic innervation measured by (123)I-mIBG imaging in patients with systolic heart failure 116
Impact of serum leptin and adiponectin levels on brain infarcts in patients with mild cognitive impairment and Alzheimer's disease: a longitudinal analysis 115
Cognitive profile in burning mouth syndrome versus mild cognitive impairment: A comparative study 115
Coinvolgimento del signaling β-adrenergico nella malattia di Alzheimer 115
Long-Term Caloric Restriction Improves Cardiac Function, Remodeling, Adrenergic Responsiveness, and Sympathetic Innervation in a Model of Postischemic Heart Failure 114
Intricate relationship between obstructive sleep apnea and dementia in older adults 113
Assessment Tools of Biopsychosocial Frailty Dimensions in Community-Dwelling Older Adults: A Narrative Review 112
G protein-coupled receptor kinase-2 svolge un ruolo cruciale nella regolare della funzione endoteliale in vivo e in vitro attraverso la modulazione del signaling del recettore B2-adrenergico. 111
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 110
Ruolo del β-bloccante sull’iperattività del Sistema Nervoso Simpatico e sulla produzione di catecolamine recettore α2 -adrenergico-dipendente dalla midollare del surrene in corso di scompenso. 109
Neuro-hormonal effects of physical activity in the elderly. 108
Potential Bidirectional Relationship Between Periodontitis and Alzheimer's Disease. 107
Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses 107
Efficacia e sicurezza della terapia con anticoagulanti rispetto agli antiaggreganti nell’insufficienza cardiac in ritmo sinusale: una revision sistematica con meta-analisi. 106
Ruolo dell’attività fisica sulla prognosi di pazienti anziani affetti da cardiopatia ischemica e sottoposti ad intervento di by-pass aorto-coronarico. 105
The elderly at risk: aldosterone as modulator of the immune response to SARS-CoV-2 infection 105
Predisposing factors to heart failure in diabetic nephropathy: a look at the sympathetic nervous system hyperactivity 104
I livelli di G-protein Coupled Receptor Kinase-2 (GRK2) linfocitaria predicono la mortalità in pazienti affetti da scompenso cardiaco avanzato. 103
Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 (grk2) Protein Levels in Patients With Heart Failure 103
Cognitive Function and Heart Failure: The Role of the Adrenergic System 103
Diabetes is Associated With Higher Lymphocyte G-Protein Coupled Receptor Kinase-2 (grk2) Protein Levels in Patients With Left Ventricle Dysfunction Independently From Heart Failure Status 102
β-adrenergic receptor responsiveness in aging heart and clinical implications 102
Neuropsychiatric symptoms and their neural correlates in individuals with mild cognitive impairment 100
Molecular aspects of the cardioprotective effect of exercise in the elderly 99
β-adrenergic receptor involvment in Alzheimer disease 99
Role of frailty on cardiac rehabilitation in hospitalized older patients 98
G protein-coupled receptor kinase-2 regola la funzione dei recettori alfa2-adrenergici ed il rilascio di catecolamine nelle cellule cromaffini umane della midollare del surrene. 98
Exercise-induced reduction of lymphocyte G-protein coupled receptor kinase-2 (GRK2) strongly predicts improved survival in patients with heart failure. 97
Sudden onset of coma in a 70-year-old woman with cryoglobulinemia 95
Blockade of ??-adrenoceptors restores the GRK2-mediated adrenal ??(2) -adrenoceptor-catecholamine production axis in heart failure 95
Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis 94
Atrial Fibrillation and Dementia: Focus on Shared Pathophysiological Mechanisms and Therapeutic Implications 93
[From bench to bedside: new insights into the treatment of heart failure]. 93
Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement: the complexity of the elderly 93
Risk of acute myocardial infarction after transurethral resection of prostate in elderly 92
Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis. 90
Sphingosine kinases and sphingosine 1-phosphate receptors: Signaling and actions in the cardiovascular system 90
Targeting the β-adrenergic receptor system through G-protein-coupled receptor kinase 2: a new paradigm for therapy and prognostic evaluation in heart failure: from bench to bedside 87
Inhibition of G-protein coupled receptor kinese 2 (grk2) by in vivo gene transfer enhances neoangiogenesis in a rat model of hindlimb ischemia. 86
Beta-adrenergic Receptor Blockade Reduces Sympathetic Overactivation in Heart Failure and Restores Adrenal GRK2-alfa2-adrenergic Receptor-cathecolamine Production Axis. 86
DIABETES IS ASSOCIATED WITH HIGHER CARDIAC SYMPATHETIC DENERVATION IN PATIENTS WITH LEFT VENTRICLE DYSFUNCTION INDEPENDENTLY FROM HEART FAILURE STATUS 84
Reperfusional strategies of STEMI in the elderly and adult population 84
Vascular Endothelial Growth Factor Blockade Prevents the Beneficial Effects of ??-Blocker Therapy on Cardiac Function, Angiogenesis and Remodeling in Heart Failure. 83
Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling 83
Lymphocyte G-Protein Coupled Receptor Kinase-2 (grk2) Levels Predict Cardiac Mortality in Patients With Advanced Heart Failure. 81
La G-protein Coupled Receptor Kinase-2 (GRK2) linfocitaria predice la mortalità cardiaca in una popolazione di pazienti anziani con insufficienza cardiaca avanzata. 78
Behavioral and psychological symptoms in dementia (BPSD) and the use of antipsychotics 77
Risk of acute myocardial infarction after transurethral resection of prostate in elderly 74
Lymphocyte G-protein coupled receptor kinase-2 (GRK2) strongly predicts survival in elderly patients with heart failure. 72
GRK2 Regulates α2-Adrenergic Receptor-Dependent Catecholamine Release in Human Adrenal Chromaffin Cells 72
Instruments for geriatric assessment: new multidimensional assessment approaches 71
Impact of diabetes mellitus on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123IMIBG) scintigraphic study 71
Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer's Disease Patients? 66
Editorial: Chronic pain in neuropsychiatric diseases 62
The emerging role of microRNAs in Alzheimer's disease 59
Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment 58
Imaging and molecular mechanisms of Alzheimer’s disease: A review 58
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study) (vol 20, 191, 2019) 54
Editorial: Molecular Mechanisms Involved in Heart Failure, Parkinson?s, and Alzheimer?s Diseases 52
Molecular mechanisms underlying adrenergic dysfunction in aging and heart failure: Clinical and therapeutical implications 48
Carcinoid-associated encephalopathy 47
T follicular helper cells (TFH): From physiological to pathological aging 46
An active lifestyle prior to coronary surgery is associated with improved survival in elderly patients. 46
The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease 46
Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using 11C-BU99008 PET and its relationship with amyloid load 46
Astrogliosis in aging and Parkinson's disease dementia: a new clinical study with 11C-BU99008 PET 45
Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging 44
Do cardiometabolic risk factors influence amyloid, tau, and neuronal function in APOE4 carriers and non-carriers in Alzheimer's disease trajectory? 43
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects? 42
Does microglial activation influence hippocampal volume and neuronal function in Alzheimer's disease and Parkinson's disease dementia? 39
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: Study protocol for a randomised controlled trial (ELAD study) 37
Parametric mapping using spectral analysis for 11 C-PBR28 PET reveals neuroinflammation in mild cognitive impairment subjects 36
Flutriciclamide (18F-GE180) PET: First-in-human PET study of novel third-generation in vivo marker of human translocator protein 34
Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume 34
The experiences of early career geriatricians throughout Europe during the COVID-19 pandemic 33
Effect of infections, DNA methylation and telomere length on frailty trajectories in hospitalized older patients: the INFRAGEN study protocol 30
Cognitive profile in burning mouth syndrome versus mild cognitive impairment: A comparative study 28
Psychological Resilience and Personality in Mild Cognitive Impairment and Healthy Older Adults 21
Mild Behavioral Impairment as a Predictor of Functional Status 16
Different association patterns of emotion regulation and heart rate variability in older and younger adults 15
Totale 8.807
Categoria #
all - tutte 30.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 3 9 14 0 0 22
2021/2022474 2 0 20 3 0 18 5 21 85 38 102 180
2022/2023761 80 24 28 47 64 96 24 76 134 126 47 15
2023/2024635 24 80 85 48 65 85 22 69 7 18 87 45
2024/20252.719 121 85 19 60 48 131 254 183 155 282 1.149 232
2025/20263.709 591 364 702 590 1.066 292 104 0 0 0 0 0
Totale 8.859